Hemetron

Zürich, Switzerland

Diagnostics Point-of-Care Testing Diagnostic Devices

Hemetron enables quantitative at-home blood testing and remote monitoring for chronic diseases, starting with rheumatology. We empower physicians to personalize treatment using accurate, quantitative self-tests, beginning with CRP for inflammatory conditions. Our platform brings lab-grade biomarker insights into patients’ homes, closing monitoring gaps that delay care and drive up costs. Backed by leading clinicians, the Innosuisse Start-up Innovation Project grant and selected as a Venture Leader Medtech 2025, Hemetron is shaping the future of precision care, starting at home.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Hemetron on @MedStartr Today #Diagnostics #PointOfCareTesting #DiagnosticDevices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/jiG8DiMipRc

Get Involved in Hemetron

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: www.hemetron.com/

Disease Areas

Diagnostics

Technologies

Diagnostic TestingIn Vitro Diagnostics

🌐Website

What do you think of Hemetron?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.